These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32146997)

  • 41. [Metformin and anesthesia].
    Landgraf R; Nawroth PP
    Anaesthesist; 2002 Jun; 51(6):491-2. PubMed ID: 12452166
    [No Abstract]   [Full Text] [Related]  

  • 42. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
    Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lactic acidosis associated (or induced by) metformin.
    Ortiz-Lasa M; Gonzalez-Castro A; Peñasco Martín Y
    Med Clin (Barc); 2017 Nov; 149(9):415-416. PubMed ID: 28865920
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs].
    Scheen AJ
    Rev Med Liege; 2002 May; 57(5):352-6. PubMed ID: 12143186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antidiabetic Drugs and the Kidney].
    Candido R
    G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960013
    [No Abstract]   [Full Text] [Related]  

  • 46. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What's the Fuss?
    Bakris GL; Molitch ME
    Diabetes Care; 2016 Jul; 39(7):1287-91. PubMed ID: 27330130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.
    Crowley MJ; Diamantidis CJ; McDuffie JR; Cameron CB; Stanifer JW; Mock CK; Wang X; Tang S; Nagi A; Kosinski AS; Williams JW
    Ann Intern Med; 2017 Feb; 166(3):191-200. PubMed ID: 28055049
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis.
    Abdel Shaheed C; Carland JE; Graham GG; Stocker SL; Smith G; Hicks M; Williams KM; Furlong T; Macdonald P; Greenfield JR; Smith FC; Chowdhury G; Day RO
    Br J Clin Pharmacol; 2019 Dec; 85(12):2772-2783. PubMed ID: 31471973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
    Almirall J; Bricullé M; Gonzalez-Clemente JM
    Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
    [No Abstract]   [Full Text] [Related]  

  • 50. Lactic acidosis due to metformin in type 2 diabetes mellitus and chronic kidney disease stage 3-5: is it significant?
    Prabhu RA; Mareddy AS; Nagaraju SP; Rangaswamy D; Guddattu V
    Int Urol Nephrol; 2019 Jul; 51(7):1229-1230. PubMed ID: 30963454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.
    Rhee CM; Kovesdy CP; Kalantar-Zadeh K
    Nephron; 2017; 135(2):147-153. PubMed ID: 27760420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review: metformin: potential benefits and use in chronic kidney disease.
    Pilmore HL
    Nephrology (Carlton); 2010 Jun; 15(4):412-8. PubMed ID: 20609092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metformin: an alternative treatment for noninsulin-dependent diabetes mellitus.
    Hitt CM
    Conn Med; 1995 Dec; 59(12):727-30. PubMed ID: 8821636
    [No Abstract]   [Full Text] [Related]  

  • 54. Metaglip and Avandamet for type 2 diabetes.
    Med Lett Drugs Ther; 2002 Dec; 44(1146):107-9. PubMed ID: 12500153
    [No Abstract]   [Full Text] [Related]  

  • 55. Does metformin do more benefit or harm in chronic kidney disease patients?
    De Broe ME; Jouret F
    Kidney Int; 2020 Nov; 98(5):1098-1101. PubMed ID: 33126974
    [No Abstract]   [Full Text] [Related]  

  • 56. Response to comment on: Smiechowski et al. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care 2013;36:124-129.
    Suissa S; Azoulay L
    Diabetes Care; 2013 Mar; 36(3):e41. PubMed ID: 23431103
    [No Abstract]   [Full Text] [Related]  

  • 57. Metformin in 2019.
    Flory J; Lipska K
    JAMA; 2019 May; 321(19):1926-1927. PubMed ID: 31009043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Toxicity of metformin, pro- or con- a future restriction to its contraindications?].
    Wakim El Khoury J; Décosterd D
    Rev Med Suisse; 2013 Aug; 9(394):1473-7. PubMed ID: 24024392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comment on: Smiechowski et al. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care 2013;36:124-129.
    Lai SW; Liao KF
    Diabetes Care; 2013 Mar; 36(3):e40. PubMed ID: 23431102
    [No Abstract]   [Full Text] [Related]  

  • 60. Metformin and ageing diabetic patients.
    Chan NN; Feher MD
    Age Ageing; 2000 Mar; 29(2):187. PubMed ID: 10791462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.